This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
ATCO or TROW: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ATCO vs. TROW: Which Stock Is the Better Value Option?
ATCO vs. TROW: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ATCO vs. TROW: Which Stock Is the Better Value Option?
Victory Capital (VCTR) October AUM Up Sequentially to $162.6B
by Zacks Equity Research
Victory Capital's (VCTR) October AUM rises 1.7%, sequentially, to $162.6 billion on higher equity asset class balances. This will likely support its financials.
T. Rowe Price's (TROW) October AUM Up 3.7% on Upbeat Markets
by Zacks Equity Research
Efforts to boost operations through planned strategies and rising AUM balance will continue supporting T. Rowe Price's (TROW) financials.
Franklin's (BEN) October AUM Rises 2.1% on Favorable Markets
by Zacks Equity Research
Steadily improving AUM balance and inorganic expansion efforts are likely to keep supporting Franklin's (BEN) financials.
AMG vs. TROW: Which Stock Is the Better Value Option?
by Zacks Equity Research
AMG vs. TROW: Which Stock Is the Better Value Option?
T. Rowe Price (TROW) Q3 Earnings Beat on Higher Revenues
by Zacks Equity Research
T. Rowe Price's (TROW) Q3 earnings reflect solid revenues and higher expenses.
T. Rowe Price (TROW) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
T. Rowe (TROW) delivered earnings and revenue surprises of -1.21% and -0.86%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
T. Rowe Price (TROW) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does T. Rowe Price (TROW) have what it takes? Let's find out.
Will Decline in AUM Hurt T. Rowe Price's (TROW) Q3 Earnings?
by Zacks Equity Research
T. Rowe's (TROW) Q3 results are likely to reflect the unfavorable impact of net outflows and elevated expenses.
Top Analyst Reports for Edwards Lifesciences, DexCom & Twitter
by Mark Vickery
Today's Research Daily features new research reports on 12 major stocks, including Edwards Lifesciences Corporation (EW), DexCom, Inc. (DXCM), and Twitter, Inc. (TWTR).
This is Why T. Rowe Price (TROW) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does T. Rowe Price (TROW) have what it takes? Let's find out.
AMG or TROW: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AMG vs. TROW: Which Stock Is the Better Value Option?
Zacks.com featured highlights include: T. Rowe Price, Best Buy, Celanese Corp, CBRE Group and Regeneron Pharma
by Zacks Equity Research
Zacks.com featured highlights include: T. Rowe Price, Best Buy, Celanese Corp, CBRE Group and Regeneron Pharma
5 High ROE Stocks to Buy as Markets Face Intense Volatility
by Supriyo Bose
T. Rowe Price Group (TROW), Best Buy (BBY), Celanese Corporation (CE), CBRE Group (CBRE), and Regeneron Pharmaceuticals (REGN) are some of the stocks with high ROE to buy in a volatile market.
Why T. Rowe Price (TROW) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does T. Rowe Price (TROW) have what it takes? Let's find out.
Victory Capital (VCTR) August AUM Rises Sequentially to $164.9B
by Zacks Equity Research
Victory Capital's (VCTR) August AUM up sequentially to $164.9 billion on higher AUM in fixed income, U.S. Mid Cap equity and U.S. Large Cap equity asset classes.
Franklin's (BEN) August AUM Rises Slightly on Market Returns
by Zacks Equity Research
Franklin's (BEN) August AUM rises sequentially on the positive impacts of markets and approximately unchanged long-term net flows.
T. Rowe Price (TROW) Reports 2.4% Hike in August AUM
by Zacks Equity Research
T. Rowe Price (TROW) sees a 2.4% increase in August AUM on a 2.4% rise in U.S. mutual fund products.
Lazard's (LAZ) August AUM Improves on Market Appreciation
by Zacks Equity Research
Lazard's (LAZ) August AUM increases 1.6% to $282.8 billion on market appreciation, and rise in balances for fixed income, equity and other assets.
Invesco (IVZ) August AUM Up 2.2% on Inflows, Upbeat Markets
by Zacks Equity Research
Steadily rising AUM balance and global footprint will keep supporting Invesco's (IVZ) revenue growth going forward.
PFG vs. TROW: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
PFG vs. TROW: Which Stock Is the Better Value Option?
This is Why T. Rowe Price (TROW) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does T. Rowe Price (TROW) have what it takes? Let's find out.
5 Stocks With High ROE as Markets Stumble on Tepid Jobs Report
by Supriyo Bose
T. Rowe Price Group (TROW), KLA Corporation (KLAC), Whirlpool Corporation (WHR), CBRE Group (CBRE) and Regeneron Pharmaceuticals (REGN) are some stocks with high ROE to buy as markets slip on weak jobs report.
The Zacks Analyst Blog Highlights: Moody's, Nasdaq, Raymond James Financial, MetLife and T. Rowe Price
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Moody's, Nasdaq, Raymond James Financial, MetLife and T. Rowe Price